Unknown

Dataset Information

Estimation of the stage-wise costs of breast cancer in Germany using a modeling approach.


ABSTRACT: Breast cancer (BC) is a heterogeneous disease representing a substantial economic burden. In order to develop policies that successfully decrease this burden, the factors affecting costs need to be fully understood. Evidence suggests that early-stage BC has a lower cost than a late stage BC. We aim to provide conservative estimates of BC's stage-wise medical costs from German healthcare and the payer's perspective. To this end, we conducted a literature review of articles evaluating stage-wise costs of BC in Germany through PubMed, Web of Science, and Econ Lit databases supplemented by Google Scholar. We developed a decision tree model to estimate BC-related medical costs in Germany using available treatment and cost information. The review generated seven studies; none estimated the stage

SUBMITTER: Khan SA 

PROVIDER: S-EPMC9853539 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature